Kaletra 80/20 Solution (Oral)
Lopinavir, Ritonavir
"80mg, 20mg/ml"
ABBVIE Inc.
Pack size | 160ml Plastic Bottle |
---|---|
Dispensing mode | POM |
Source | USA |
Agent | CITY MEDICAL STORE |
Retail Price | 928.00 AED |
Indications
Kaletra 80/20 Solution (Oral) is used for:
LOPINAVIR
Indicated in combination with other antiretroviral agents for the treatment of hiv-infection
RITONAVIR
Indicated in combination with other antiretroviral agents for the treatment of hiv-infection
Indicated in combination with other antiretroviral agents for the treatment of hiv-infection
RITONAVIR
Indicated in combination with other antiretroviral agents for the treatment of hiv-infection
Adult Dose
Child Dose
Renal Dose
Administration
Contra Indications
Precautions
Pregnancy-Lactation
Interactions
Adverse Effects
Side effects of Lopinavir, Ritonavir :
Mechanism of Action
LOPINAVIR
Lopinavir inhibits the hiv viral protease enzyme. This prevents cleavage of the gag-pol polyprotein and, therefore, improper viral assembly results. This subsequently results in non-infectious, immature viral particles
RITONAVIR
Ritonavir inhibits the hiv viral proteinase enzyme which prevents cleavage of the gag-pol polyprotein, resulting in noninfectious, immature viral particles
Lopinavir inhibits the hiv viral protease enzyme. This prevents cleavage of the gag-pol polyprotein and, therefore, improper viral assembly results. This subsequently results in non-infectious, immature viral particles
RITONAVIR
Ritonavir inhibits the hiv viral proteinase enzyme which prevents cleavage of the gag-pol polyprotein, resulting in noninfectious, immature viral particles
Note
Kaletra 80/20 "80mg, 20mg/ml" Solution (Oral) manufactured by ABBVIE Inc.. Its generic name is Lopinavir, Ritonavir. Kaletra 80/20 is availble in United Arab Emirates.
Farmaco UAE drug index information on Kaletra 80/20 Solution (Oral) is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.